-
Sensex, Nifty may open in green post robust macroeconomic data
India's GDP for 2020-21 contracted by 7.3%, even as GDP for the year's last quarter (January-March 2021) grew by 1.6%, official data released by the N
-
Covid-19 super spreaders: Surat starts green, white card plan
Deputy Municipal Commissioner Ashish Naik said those who had not been vaccinated or even tested for the virus would be given white health cards
-
What is revenge spending and how will it impact these stocks? Check it out
China was the first country to witness the trend of revenge spending after lockdown
-
Pfizer skids after Q4 PAT slips 2% to Rs 101 crore
In India, the COVID-19 pandemic continued to develop rapidly into 2021, with a significant rise in the number of cases.
-
Delhi government puts cap on oxygen cylinder transportation charges
According to the order, the maximum transportation cost of a B-type oxygen cylinder has been fixed at Rs 50, while for D-type and Jumbo-type, it has b
-
Panacea Biotec hits upper circuit on commencing production of Sputnik V vaccine
The first batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Center for quality control.
-
Higher retail participation is increasing liquidity risks for Indian markets: JPMorgan
Institutional participation, including domestic and foreign, is close to 14-year lows
-
Delhi records 3,231 fresh Covid-19 cases, 233 deaths; positivity rate slips to 5.5%
Delhi on Thursday recorded 3,231 Covid-19 cases, the daily count dipping to below 4,000-mark for the second consecutive day
-
These five key changes can make your investment portfolio Covid-proof
Concerns over Covid-19 and ongoing state-wise restrictions have turned the equity investors cautious on Dalal Street. However, analysts continued to r
-
Dr Reddy’s: Riding strong on Covid opportunities
The company's existing range of Covid-19 therapeutics cover the full spectrum from mild to moderate and severe conditions of the disease
